Clinical Psychopharmacology and Neuroscience indexed in CAS, DOI/Crossref, EMBASE, Korea Citation Index (KCI), KoreaMed, Korea Medical Citation Index (KoMCI), PubMed, PubMed Central (PMC), SCOPUS, SCI-expanded (SCIE), and Google Scholar:eISSN 2093-4327   pISSN 1738-1088

Download original image
Fig. 3. Group path lengths averaged across each trial of four days. Bars for control (n = 17), sham (n = 13), hypoxic-ischemic encephalopathy (HIE, n = 16), pentoxifylline (PTX) 60 (n = 20) and PTX100 (n = 11) are mean ± standard error.

*p < 0.05 versus control group; p < 0.05 versus sham group; p < 0.05 versus control and sham groups; §p < 0.05 versus control, sham and PTX100 groups.

Clinical Psychopharmacology and Neuroscience 2019;17:388~399 https://doi.org/10.9758/cpn.2019.17.3.388
© Clin Psychopharmacol Neurosci